Energy deposition and receptor saturation set a tumour size threshold for radiopharmaceutical therapy: insights from a pharmacokinetic-tumour dynamics model
Elahe Mollaheydar, Babak Saboury, Arman Rahmim, Eric N. Cytrynbaum
This study develops a pharmacokinetic-tumour dynamics model to show that tumour size and receptor expression, rather than injected dose, primarily determine radiopharmaceutical therapy outcomes.
bioRxiv · May 28, 2025 · PreprintCancer Biology